170 related articles for article (PubMed ID: 17493461)
1. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
Cavusoglu E; Ruwende C; Eng C; Chopra V; Yanamadala S; Clark LT; Pinsky DJ; Marmur JD
Am J Cardiol; 2007 May; 99(10):1364-8. PubMed ID: 17493461
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome.
Cavusoglu E; Chopra V; Gupta A; Clark LT; Eng C; Marmur JD
Am J Cardiol; 2006 Sep; 98(5):580-4. PubMed ID: 16923440
[TBL] [Abstract][Full Text] [Related]
3. Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography.
Cavusoglu E; Eng C; Chopra V; Clark LT; Pinsky DJ; Marmur JD
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):929-35. PubMed ID: 17255538
[TBL] [Abstract][Full Text] [Related]
4. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography.
Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Pinsky DJ; Marmur JD
Coron Artery Dis; 2009 Mar; 20(2):112-7. PubMed ID: 19240644
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction.
Mocatta TJ; Pilbrow AP; Cameron VA; Senthilmohan R; Frampton CM; Richards AM; Winterbourn CC
J Am Coll Cardiol; 2007 May; 49(20):1993-2000. PubMed ID: 17512353
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain.
Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Clark LT; Pinsky DJ; Marmur JD
Eur Heart J; 2006 Oct; 27(19):2300-9. PubMed ID: 16864609
[TBL] [Abstract][Full Text] [Related]
8. Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome.
Cavusoglu E; Marmur JD; Hojjati MR; Chopra V; Butala M; Subnani R; Huda MS; Yanamadala S; Ruwende C; Eng C; Pinsky DJ
Am J Med; 2011 Aug; 124(8):724-30. PubMed ID: 21787901
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of myeloperoxidase in patients with chest pain.
Brennan ML; Penn MS; Van Lente F; Nambi V; Shishehbor MH; Aviles RJ; Goormastic M; Pepoy ML; McErlean ES; Topol EJ; Nissen SE; Hazen SL
N Engl J Med; 2003 Oct; 349(17):1595-604. PubMed ID: 14573731
[TBL] [Abstract][Full Text] [Related]
10. Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Samimi-Fard S; Dominguez-Rodriguez A; Abreu-Gonzalez P; Enjuanes-Grau C; Blanco-Palacios G; Hernandez-Baldomero IF; Bosa-Ojeda F; Marrero-Rodríguez F
Am J Cardiol; 2009 Sep; 104(5):634-7. PubMed ID: 19699336
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.
Goldmann BU; Rudolph V; Rudolph TK; Holle AK; Hillebrandt M; Meinertz T; Baldus S
Free Radic Biol Med; 2009 Jul; 47(1):79-83. PubMed ID: 19362143
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
Tang WH; Iqbal N; Wu Y; Hazen SL
Am J Cardiol; 2013 Feb; 111(4):465-70. PubMed ID: 23219176
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
Dominguez-Rodriguez A; Samimi-Fard S; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
Am J Cardiol; 2008 Jun; 101(11):1537-40. PubMed ID: 18489929
[TBL] [Abstract][Full Text] [Related]
14. [Myeloperoxidase in the plasma of patients with acute coronary syndrome].
Ouyang M; Yang K; Zhang MX; Jiang WH; Cao Y; Wang JG; Gao YD
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):901-5. PubMed ID: 17213593
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic performance of myeloperoxidase plasma levels compared with sensitive troponins in patients admitted with acute onset chest pain.
Rudolph V; Keller T; Schulz A; Ojeda F; Rudolph TK; Tzikas S; Bickel C; Meinertz T; Münzel T; Blankenberg S; Baldus S
Circ Cardiovasc Genet; 2012 Oct; 5(5):561-8. PubMed ID: 22923422
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
Peacock WF; Nagurney J; Birkhahn R; Singer A; Shapiro N; Hollander J; Glynn T; Nowak R; Safdar B; Miller C; Peberdy M; Counselman F; Chandra A; Kosowsky J; Neuenschwander J; Schrock J; Plantholt S; Lewandrowski E; Wong V; Kupfer K; Diercks D
Am Heart J; 2011 Nov; 162(5):893-9. PubMed ID: 22093206
[TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction.
Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Clark LT; Pinsky DJ; Marmur JD
Am Heart J; 2006 May; 151(5):1101.e1-8. PubMed ID: 16644343
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
Marshall CJ; Nallaratnam M; Mocatta T; Smyth D; Richards M; Elliott JM; Blake J; Winterbourn CC; Kettle AJ; McClean DR
Am J Cardiol; 2010 Aug; 106(3):316-22. PubMed ID: 20643239
[TBL] [Abstract][Full Text] [Related]
20. Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
Tang WH; Wu Y; Nicholls SJ; Hazen SL
Clin Chem; 2011 Jan; 57(1):33-9. PubMed ID: 21059827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
